SUBSTITUTED STRAIGHT CHAIN SPIRO DERIVATIVES
The present invention relates to pharmaceutical agents useful for therapy and/or prophylaxis in a mammal, pharmaceutical composition comprising such compounds, and their use as menin/MLL protein/protein interaction inhibitors, useful for treating diseases such as cancer, including but not limited to...
Saved in:
Main Authors | , , , , , , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
26.10.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to pharmaceutical agents useful for therapy and/or prophylaxis in a mammal, pharmaceutical composition comprising such compounds, and their use as menin/MLL protein/protein interaction inhibitors, useful for treating diseases such as cancer, including but not limited to leukemia, myelodysplastic syndrome (MDS), and myeloproliferative neoplasms (MPN); and diabetes. |
---|---|
Bibliography: | Application Number: EP20200902289 |